Larson Financial Group
OCUL icon

Larson Financial Group’s Ocular Therapeutix OCUL Stock Holding History

Larson Financial Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$153 Sell
20
-32
-62% -$313 ﹤0.01% 3717
2026
Q2 		$511 Hold
52
– – ﹤0.01% 3478
2026
Q1 		$440 Sell
52
-14
-21% -$133 ﹤0.01% 3335
2025
Q4 		$801 Buy
66
+57
+633% +$692 ﹤0.01% 3016
2025
Q3 		$105 Buy
9
+1
+13% +$12 ﹤0.01% 3326
2025
Q2 		$74 Buy
+8
New +$63 ﹤0.01% 3197

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $135M AUM 15.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
Empire Life Investments
Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Larson Financial Group's OCUL Position: Q3 2026 in Review

Larson Financial Group reduced its Ocular Therapeutix (OCUL) stake by 62% in Q3 2026, selling an estimated $313 and leaving 20 shares worth $153. The position accounts for ﹤0.01% of the portfolio, ranked #3717.

Larson Financial Group first reported a position in OCUL in Q2 2025 and has held it in 6 quarters since. The position peaked at $801 in Q4 2025. 87 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Larson Financial Group held 20 shares of Ocular Therapeutix worth $153 as of Q3 2026.
  • Larson Financial Group sold 32 Ocular Therapeutix shares in Q3 2026, an estimated $313.
  • Ocular Therapeutix made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3717 holding.
  • Larson Financial Group first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Ocular Therapeutix position peaked at $801 in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.